Atabak Mokari - Feb 9, 2024 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Financial Officer
Signature
/s/ Joseph Douglas Lyon, as attorney in fact for Atabak Mokari
Stock symbol
CORT
Transactions as of
Feb 9, 2024
Transactions value $
$0
Form type
4
Date filed
2/13/2024, 07:40 PM
Previous filing
Dec 5, 2023
Next filing
Mar 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock option (right to buy) Award $0 +200K $0.00 200K Feb 9, 2024 Common Stock 200K $23.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable ratably in equal installments on each monthly anniversary of February 9, 2024 over a four-year period.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.